Envoy Medical, Inc.
COCH· Nasdaq
Filed Apr 1, 2024 · 10-K · 92 days after period end · 0001213900-24-028894
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|
| Revenue | $95.00K | — | — |
| Net Income | -$4.90M | -$11.48M | -$4.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 1, 2024 · 92 d after period end